['rheumatoid arthritis']
['etanercept', 'chs-0214']

        Inclusion Criteria:

          -  Male or female adults

          -  RA (Rheumatoid Arthritis) diagnosis for 6 months

          -  On stable dose of MTX of 8mg to 25mg per week

          -  Active disease: greater than 6 tender joints, greater than 6 swollen joints,
             C-reactive protein (CRP) greater than or equal to 0.5mg/dL, and disease activity score
             (DAS) with 28 joints (DAS28-CRP(4)) greater than or equal to 3.2

        Exclusion Criteria:

          -  Use of prednisone greater than 10mg/day

          -  Use of greater than one non-steroidal anti-inflammatory drug (NSAID)

          -  Use of biologic therapies for any cause

          -  Chemistry and hematology values outside protocol specified range

          -  Positive QuantiFERON-tuberculosis (TB) Gold Test

          -  Evidence of active lung disease on chest x-ray

          -  Major systemic infections

          -  Presence of significant comorbid conditions

          -  Known allergy to latex

          -  Women who are pregnant or nursing
      